Şahin, Sevtap HekimoğluÖztekin, İlhanKuzucuoğlu, AytunaAslanoğlu, Ayça2021-11-202021-11-2020152146-31232146-3131https://app.trdizin.gov.tr/makale/TVRjek5qUTJOZz09https://hdl.handle.net/20.500.14551/5473Background: Wolff-Parkinson-White (WPW) syndrome is a disease associated with episodes of supra- ventricular tachycardia and ventricular pre-excitation or atrial fibrillation. WPW is characterized by an aber- rant electrical conduction pathway between atria and ventricles. Case Report: The major anesthetic problem connected with WPW syndrome is the risk of tachyarrhythmias due to accessory pathway. Therefore, it has been pro- posed that the aim of anesthetic management should be the avoidance of tachyarrhythmia and sympathetic stimulation. Sugammadex was administered as a neu- romuscular reversal agent in this case. To our knowl- edge, this is the first case report of sugammadex use in a patient with WPW. This report presents a case of general anesthesia management in a patient with WPW syndrome. Conclusion: We think that it is appropriate to use su- gammadex to reverse rocuronium for the prevention of sudden hemodynamic changes in patients with WPW who underwent general anesthesia.en10.5152/balkanmedj.2014.15155info:eu-repo/semantics/openAccessCerrahiArticle323327329Q4WOS:00035733060001726185726173646